PNC Financial Services Group
FULC icon

PNC Financial Services Group’s Fulcrum Therapeutics FULC Stock Holding History

PNC Financial Services Group’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.02K Buy
1,356
+1,279
+1,661% +$4.8K ﹤0.01% 4508
2026
Q2 		$282 Sell
77
-808
-91% -$4.92K ﹤0.01% 5070
2026
Q1 		$6.79K Sell
885
-557
-39% -$5.17K ﹤0.01% 4127
2025
Q4 		$16.3K Buy
1,442
+25
+2% +$254 ﹤0.01% 3759
2025
Q3 		$13K Sell
1,417
-32
-2% -$232 ﹤0.01% 3823
2025
Q2 		$10K Buy
1,449
+923
+175% +$4.94K ﹤0.01% 3872
2025
Q1 		$1.52K Buy
526
+521
+10,420% +$1.91K ﹤0.01% 4421
2024
Q4 		$24 Buy
+5
New +$18 ﹤0.01% 4755

Other funds holding FULC

Renaissance Technologies
Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return
GSK plc
GSK plc London $497M AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $57.2B AUM 42.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

PNC Financial Services Group's FULC Position: Q3 2026 in Review

PNC Financial Services Group increased its Fulcrum Therapeutics (FULC) stake by 1,661% in Q3 2026, buying an estimated $4.8K and bringing the position to 1,356 shares worth $5.02K. The position accounts for ﹤0.01% of the portfolio, ranked #4508.

PNC Financial Services Group first reported a position in FULC in Q4 2024 and has held it in 8 quarters since. The position peaked at $16.3K in Q4 2025. 75 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • PNC Financial Services Group held 1,356 shares of Fulcrum Therapeutics worth $5.02K as of Q3 2026.
  • PNC Financial Services Group bought 1,279 Fulcrum Therapeutics shares in Q3 2026, an estimated $4.8K.
  • Fulcrum Therapeutics made up ﹤0.01% of PNC Financial Services Group's portfolio in Q3 2026, its #4508 holding.
  • PNC Financial Services Group first reported a position in Fulcrum Therapeutics in Q4 2024 and has held it in 8 quarters since.
  • PNC Financial Services Group's Fulcrum Therapeutics position peaked at $16.3K in Q4 2025.
  • 75 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on PNC Financial Services Group's 13F filing for Q3 2026, filed 6 Nov 2026.